Calderon-Goercke, MonicaLoricera, J.Prieto-Pena, D.Aldasoro, VicenteCastaneda, SantosVilla-Blanco, IgnacioHumbria, AliciaMoriano, ClaraRomero-Yuste, SusanaNarvaez, J.Gomez-Arango, CatalinaPerez-Pampin, EvaMelero, RafaelBecerra-Fernandez, ElenaRevenga, MarcelinoAlvarez-Rivas, NoeliaGalisteo, CarlesSivera, FranciscaOlive, AlejandroAlvarez del Buergo, MariaMarena Rojas, LuisaFernandez-Lopez, CarlosNavarro, FranciscoRaya, EnriqueGalindez, EvaArca, BeatrizSolans-Laque, RoserConesa, ArantxaHidalgo, CristinaVazquez, CarlosAndres Roman-Ivorra, JoseLluch, PauManrique Arija, SaraVela-Casasempere, Palomade Miguel, EugenioTorres-Martin, CarmenCarlos Nieto, JuanOrdas-Calvo, CarmenSalgado-Perez, EvaLuna-Gomez, CristinaToyos Saenz de Miera, J. FranciscoFernandez-Llanio, NagoreGarcia, AntonioLarena, CarmenPalmou-Fontana, NataliaCalvo-Rio, VanesaGonzalez-Vela, CarmenCorrales, AlfonsoVarela-Garcia, MariaAurrecoechea, ElenaDos-Santos, RaquelGarcia-Manzanares, AngelOrtego, NorbertoFernandez, SabelaOrtiz-Sanjuan, FranciscoCorteguera, MontserratLuis Hernandez, J.Gonzalez-Gay, Miguel A.Blanco, Ricardo2025-01-072025-01-072019-06-010003-4967https://hdl.handle.net/10668/25983enEFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS INDEPENDENTLY OF THE INICIAL PREDNISONE DOSEconference outputopen access10.1136/annrheumdis-2019-eular.22091468-2060https://ard.bmj.com/content/annrheumdis/78/Suppl_2/1185.full.pdf472207103405